BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 17457192)

  • 1. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
    Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
    Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tear interleukin-6 levels in patients with Sjögren syndrome.
    Tishler M; Yaron I; Geyer O; Shirazi I; Naftaliev E; Yaron M
    Ophthalmology; 1998 Dec; 105(12):2327-9. PubMed ID: 9855167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome.
    Argüeso P; Balaram M; Spurr-Michaud S; Keutmann HT; Dana MR; Gipson IK
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1004-11. PubMed ID: 11923240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of inflammatory cytokines in the tears of dry eye patients.
    Massingale ML; Li X; Vallabhajosyula M; Chen D; Wei Y; Asbell PA
    Cornea; 2009 Oct; 28(9):1023-7. PubMed ID: 19724208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
    Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
    Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
    Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
    Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
    Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
    Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival in vivo confocal scanning laser microscopy in patients with Sjögren syndrome.
    Wakamatsu TH; Sato EA; Matsumoto Y; Ibrahim OM; Dogru M; Kaido M; Ishida R; Tsubota K
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):144-50. PubMed ID: 19696170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
    Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
    Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
    Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
    Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
    Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory markers in the tears of patients with ocular surface disease.
    Acera A; Rocha G; Vecino E; Lema I; Durán JA
    Ophthalmic Res; 2008 Oct; 40(6):315-21. PubMed ID: 18688174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
    Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
    Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
    Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease.
    Choi W; Lian C; Ying L; Kim GE; You IC; Park SH; Yoon KC
    Curr Eye Res; 2016 Sep; 41(9):1143-9. PubMed ID: 26731289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
    Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
    Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory molecules in the tears of patients with keratoconus.
    Lema I; Durán JA
    Ophthalmology; 2005 Apr; 112(4):654-9. PubMed ID: 15808258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.